Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

QR-333 safely reduces symptoms of diabetic peripheral neuropathy

Sep. 22, 2005

Pegvisomant treatment benefits patients with acromegaly

Sep. 22, 2005

New agents for treating obesity disclosed in recent patent literature

Sep. 21, 2005

Update on the antidiabetic effects of muraglitazar

Sep. 21, 2005

JTT-010: A novel PKCbeta inhibitor with therapeutic benefits in diabetic complications

Sep. 21, 2005

KB-2115 shows promise in phase Ia trials

Sep. 21, 2005

Update on the benefits of insulin glulisine in diabetes

Sep. 21, 2005

Zoledronic acid reported more effective than risedronate in Paget's disease of the bone

Sep. 21, 2005

PSN-9301 in combination with metformin improves glucose tolerance in two rat models of diabetes

Sep. 20, 2005

rhGAD65 DNA vaccine prevents insulitis, beta cell apoptosis and diabetes onset in NOD mice

Sep. 20, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...